Predicting Radiation Resistance in Breast Cancer with Expression Status of Phosphorylated S6K1
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predicting Radiation Resistance in Breast Cancer with Expression Status of Phosphorylated S6K1
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-20
DOI
10.1038/s41598-020-57496-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MASTL inhibition promotes mitotic catastrophe through PP2A activation to inhibit cancer growth and radioresistance in breast cancer cells
- (2018) Yi Na Yoon et al. BMC CANCER
- Updated ASTRO guidelines on accelerated partial breast irradiation (APBI): to whom can we offer APBI outside a clinical trial?
- (2018) Anna M Kirby BRITISH JOURNAL OF RADIOLOGY
- Role of metabolism in cancer cell radioresistance and radiosensitization methods
- (2018) Le Tang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- NCCN Guidelines Updates: Breast Cancer
- (2018) Sharon H. Giordano et al. Journal of the National Comprehensive Cancer Network
- Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer
- (2018) Chelain R. Goodman et al. JAMA Oncology
- Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer
- (2017) Yun Gyoung Kim et al. Oncotarget
- Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma in vitro and in vivo
- (2017) Chih-Chia Yu et al. Oncotarget
- Analysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor–Positive, HER2-Negative Early Breast Cancer
- (2016) Hamdy A. Azim et al. Translational Oncology
- Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer
- (2015) C. Speers et al. CLINICAL CANCER RESEARCH
- Advances in the Molecular Analysis of Breast Cancer: Pathway toward Personalized Medicine
- (2015) Marilin Rosa Cancer Control
- Cancer stem cells and radioresistance
- (2014) Kiera Rycaj et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Breast cancer subtypes: response to radiotherapy and potential radiosensitisation
- (2013) F E Langlands et al. BRITISH JOURNAL OF RADIOLOGY
- Radioresistant Cancer Cells Can Be Conditioned to Enter Senescence by mTOR Inhibition
- (2013) H. Y. Nam et al. CANCER RESEARCH
- Combining mTOR Inhibition with Radiation Improves Antitumor Activity in Bladder Cancer Cells In Vitro and In Vivo: A Novel Strategy for Treatment
- (2013) Roland Nassim et al. PLoS One
- Targeting a cornerstone of radiation resistance: Cancer stem cell
- (2012) Coralie Moncharmont et al. CANCER LETTERS
- The role of S6K1 in ER-positive breast cancer
- (2012) Marina K. Holz CELL CYCLE
- Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy
- (2012) Justin Cidado et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer
- (2012) Helena Mauceri ONCOLOGY REPORTS
- Expression of thioredoxin system and related peroxiredoxin proteins is associated with clinical outcome in radiotherapy treated early stage breast cancer
- (2011) Caroline M. Woolston et al. RADIOTHERAPY AND ONCOLOGY
- Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast cancer
- (2010) Eun-Kyu Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
- (2010) Gizeh Pérez-Tenorio et al. BREAST CANCER RESEARCH AND TREATMENT
- Chloride intracellular channel 1 identified using proteomic analysis plays an important role in the radiosensitivity of HEp-2 cells via reactive oxygen species production
- (2010) Jae-Sung Kim et al. PROTEOMICS
- Everolimus
- (2009) Michael B. Atkins et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search